La cadena de opciones muestra datos clave de las opciones de acciones de Corteva a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Corteva..

Corteva (NYSE:CTVA) Bolsa, Cadena de Opciones

Corteva

Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.

Corteva Inc

Loop Capital analyst Chris Dankert maintains Applied Industrial Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) with a Buy and lowers the price target from $320 to $290.

News

Price Target

Analyst Ratings

Loop Capital Maintains Buy on Applied Industrial Techs, Lowers Price Target to $290

WIIM

TFIN

Triumph Financial shares are trading lower after the company reported worse-than-expected Q1 revenue results.

IIIN

Insteel Industries shares are trading higher after the company reported a Q2 revenue beat.

Badget Meter shares are trading higher after the company reported Q1 financial results and beat its EPS and sales estimates.

SMCI

Super Micro Computer shares are trading lower after JP Morgan cut its price target on the stock from $45 to $39.

U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) reported better-than-expected first-quarter <a href="https://www.benzinga.com/quote/USB/earnings">earnings on Wednesday.</a>
The company posted earnings per share of $1.03, which beat the analyst consensus estimate of 98 cents. The parent company of U.S. Bank reported quarterly revenues of $6.95 billion. It outpaced the analyst consensus estimate of $6.91 billion.
U.S. Bancorp's average total loans increased 2.1% on a year-over-year basis and 0.9% on a linked quarter basis.
"We managed expenses with discipline and delivered 270 basis points of positive operating leverage on an adjusted basis – our third consecutive quarter of yearover-year growth in revenues outpacing expenses," said U.S. Bancorp CEO Gunjan Kedia.
U.S. Bancorp shares gained 1.6% to trade at $38.40 on Thursday.
These analysts made changes to their price targets on U.S. Bancorp following earnings announcement.
<ul>
<li>Keefe, Bruyette &amp; Woods analyst David Konrad maintained U.S. Bancorp with a Market Perform rating and lowered the price target from $54 to $49.</li>
<li>Truist Securities analyst John McDonald maintained the stock with a Hold rating and cut the price target from $51 to $48.</li>
<li>Barclays analyst Jason Goldberg maintained U.S. Bancorp with an Overweight rating and lowered the price target from $61 to $56.</li>
</ul>
Considering buying USB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="598" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111611/image-26-1024x598.png" alt="" class="wp-image-877017" style="width:531px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111611/image-26-1024x598.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111611/image-26-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111611/image-26-768x448.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111611/image-26.png 1067w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44866413/netflix-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-3">Netflix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a> </li>
</ul>
Photo via Shutterstock

Earnings

Markets

Trading Ideas

U.S. Bancorp Analysts Slash Their Forecasts After Q1 Earnings

NDRA

ENDRA Life Sciences Shares Halted On Circuit Breaker To The Upside, Stock Now Up 57.6%

HBAN

Huntington Bancshares shares are trading higher after the company reported better-than-expected Q1 financial results and approved a $1 billion stock repurchase program.

AngloGold Ashanti shares are trading lower after HSBC downgraded the stock from Hold to Reduce and announced a price target of $35.

FANG

Diamondback Energy shares are trading higher after Truist Securities raised its price target on the stock from $238 to $242 and maintained a Buy rating.

Investment advisor Ross Gerber is calling out what he sees as unfair treatment in President Donald Trump&#8217;s tariff policy, accusing the administration of protecting corporate giants while leaving small businesses to suffer.
&#8220;So all the small businesses get to struggle and go [bankrupt] while Trump makes exceptions for most other Chinese imports from the [Magnificent] 7,&#8221; Gerber <a href="https://x.com/GerberKawasaki/status/1911086217044918298">posted</a> on X. &#8220;This is not only absurd, but just wrong. It's the art of the steal.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">So all the small businesses get to struggle and go BK while Trump makes exceptions for most other Chinese imports from the mag 7. This is not only absurd, but just wrong. It's the art of the steal.
&mdash; Ross Gerber (@GerberKawasaki) <a href="https://twitter.com/GerberKawasaki/status/1911086217044918298?ref_src=twsrc%5Etfw">April 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>Invest in the future of digital engagement: <a href="https://www.benzinga.com/money/vatom-adv">Own a piece of the $100 billion Metaverse for just $500</a>.</li>
</ul>
<h2 class="wp-block-heading">Big Tech Gets a Break</h2>
Gerber&#8217;s frustration followed news that the Trump administration had <a href="https://www.benzinga.com/25/04/44778464/trump-administration-grants-tariff-reprieve-to-tech-industry-apple-and-nvidia-among-beneficiaries">granted tariff exemptions</a> for smartphones, laptops and other electronics — a major win for tech firms like Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>). These products had been subject to steep import taxes as part of Trump's aggressive trade crackdown on China.
U.S. Customs and Border Protection listed the exemptions late Friday, applying retroactively from April 5. The list included semiconductors, memory chips and flat-panel displays—all critical components for companies in the so-called &#8220;Magnificent 7,&#8221; a group of high-performing tech stocks.
<h2 class="wp-block-heading">Small Businesses Say They're Getting Crushed</h2>
Critics say the carveouts expose a double standard. &#8220;Tariffs against big-tech Apple: ZERO. Tariffs against Mom-and-Pop Main Street businesses: 145%,&#8221; <a href="https://x.com/acedawg22/status/1911127552489369807">posted</a> a person in response to Gerber. Another user wrote: &#8220;Let them eat cake!&#8221;
Trending: With shares starting at $1.52, <a href="https://www.benzinga.com/money/how-a-10k-bet-on-health-care-originals-could-have-skyrocketed-your-portfolio">this could be your chance to invest in the future of healthcare</a>.
In an April 4 <a href="https://www.youtube.com/watch?v=zLnX1SQfgJI">interview</a> with Tucker Carlson, Treasury Secretary Scott Bessent argued the stock drop wasn't Trump's fault. &#8220;If I were to analyze&#8230; what's happening with the market, I'd say it's more a Mag 7 problem, not a MAGA one,&#8221; Bessent said, blaming the downturn on China's new AI tool, <a href="https://www.benzinga.com/topic/deepseek">DeepSeek</a>, rather than the president's economic policies.
But many economists and even Federal Reserve officials disagree, pointing to the market chaos and inflation fears triggered by Trump's escalating tariff war. Consumer confidence has plunged, and the S&amp;P 500 has seen its wildest swings since the 2020 pandemic.
<h2 class="wp-block-heading">Relief Might Not Last</h2>
Any relief for tech companies could be short-lived. On Sunday, Trump posted that the excluded products were still subject to the existing 20% fentanyl-related tariffs and would be reassigned under a new national security investigation.
&#8220;There was no tariff &#8216;exception&#8217;,&#8221; Trump wrote on <a href="https://truthsocial.com/@realDonaldTrump/posts/114332337028519855">Truth Social</a>. &#8220;These products are just moving to a different tariff &#8216;bucket.'&#8221;
See Also: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">invest pre-IPO from $0.60 per share now</a>.
Commerce Secretary Howard Lutnick confirmed the administration plans to impose new duties within two months targeting semiconductors, smartphones and computers. &#8220;These are things that are national security, that we need to be made in America,&#8221; Lutnick told <a href="https://www.youtube.com/watch?v=cYGb2Sgy_Vk">ABC News</a>.
Critics like Sen. Elizabeth Warren (D-MA) blasted the administration's inconsistent moves. &#8220;There is no tariff policy — only chaos and corruption,&#8221; she <a href="https://www.youtube.com/watch?v=eTNcjSsxBVY">said</a> Sunday on ABC's &#8220;This Week.&#8221;
<h2 class="wp-block-heading">Market Mayhem</h2>
The on-again, off-again nature of Trump's tariff strategy has sent <a href="https://www.benzinga.com/25/04/44774499/wall-street-panic-extends-to-main-street-as-us-china-trade-war-escalates-bond-vigilantes-make-a-comeback-this-week-in-markets">shock waves</a> through the economy. Investors have dumped bonds, the <a href="https://www.benzinga.com/markets/equities/25/04/44768702/foreigners-dump-the-dollar-gold-and-yen-act-as-safe-haven-jpmorgan-helps-stock-market-cooler-ppi">dollar has slumped</a> and gold has hit record highs. China, meanwhile, slapped a <a href="https://www.benzinga.com/markets/25/04/44756353/xi-jinping-says-there-are-no-winners-in-tariff-war-as-china-slaps-125-tariffs-on-us-goods-urges-trump-to-immediately-correct-wrongdoings">125% retaliatory tariff on U.S. goods</a> and warned that any future hikes would be ignored.
Despite the turbulence, Bessent insisted the administration maintains a &#8220;strong-dollar policy&#8221; and dismissed suggestions that tariffs are a backdoor attempt to devalue the currency.
Read Next:
<ul>
<li>BlackRock is calling 2025 the year of alternative assets. <a href="https://www.benzinga.com/money/masterworks">One firm from NYC has quietly built a group of 60,000+ investors who have all joined in on an alt asset class previously exclusive to billionaires like Bezos and Gates.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>

AAPL

DELL

NVDA

'Art Of The Steal'—Ross Gerber Says Small Businesses Get To 'Go Bankrupt' While Trump Makes Exceptions For MAG 7 Chinese Imports

The <a href="https://www.benzinga.com/topic/cybersecurity">cybersecurity sector</a> may be breathing a sigh of relief after a deal was reached to continue funding for the Common Vulnerabilities and Exposures database, commonly known as the CVE program.
What Happened: The 25-year-old CVE program is used to identify cybersecurity vulnerabilities and has been considered a vital part of <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44501515/cybersecurity-stocks-to-outperform-its-the-one-line-item-that-no-company-in-the-world-is-cutting-josh-brown">the cybersecurity sector.</a>
News spread this week that funding for the CVE program expired on April 16 and a contract with the U.S. Department of Homeland Security had not been renewed. However, in a last-minute turnaround, the program was reinstated, according to a Forbes <a href="https://www.forbes.com/sites/kateoflahertyuk/2025/04/16/cve-program-funding-cut-what-it-means-and-what-to-do-next/">report</a>.
"The CVE Program is invaluable to cyber community and a priority of CISA. Last night, CISA executed the option period on the contract to ensure there will be no lapse in critical CVE services," a CISA (Cybersecurity and Infrastructure Security Agency) spokesperson told Forbes.
The report said the CISA's extension of funding will last 11 months.
A new body, which includes a subset of the CVE Board, will break off and maintain the CVE Program, according to the report. 
"The CVE Foundation has been formally established to ensure the long-term viability, stability, and independence of the Common Vulnerabilities and Exposures Program, a critical pillar of the global cybersecurity infrastructure for 25 years," the new CVE governing body said.
Read Also: <a href="https://www.benzinga.com/etfs/sector-etfs/25/03/44241995/cybersecurity-report-flags-7-major-threats-against-governments-corporations-stocks-and-etfs-to-watch">Cybersecurity Report Flags 7 Major Threats Against Governments, Corporations: Stocks And ETFs To Watch</a>
Why It's Important: Experts warned that the end of the CVE Program could lead to increased vulnerabilities in the cybersecurity sector.
"Without CVE, defenders are at a massive disadvantage against global cyber threats," CVE Board Member Kent Landfield said. "CVE, as a cornerstone of the global cybersecurity ecosystem, is too important to be vulnerable itself."
If the CVE had not been able to continue its funding, the list of logged vulnerabilities would have ended, and organizations could have been more vulnerable to attacks.
The funding extension eases worries temporarily but leaves questions about the future of the CVE, which comes as cybersecurity attacks have increased and remain a key concern for large companies.
Investors seeking exposure to the cybersecurity sector have several options, including individual stocks and ETFs. These are the largest ETFs covering the sector:
<ul>
<li>First Trust Nasdaq Cybersecurity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIBR#NASDAQ">CIBR</a>)</li>
<li>Amplify Cybersecurity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HACK#NYSE">HACK</a>)</li>
<li>Global X Cybersecurity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BUG#NASDAQ">BUG</a>)</li>
<li>iShares Cybersecurity And Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHAK#NYSE">IHAK</a>)</li>
</ul>
In the ETFs, some of the top holdings include CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>), Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) and Okta Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>).
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44859945/whistleblower-alleges-doge-involved-in-major-cybersecurity-breach-at-us-labor-agency">Whistleblower Says DOGE May Have Caused Major Cybersecurity Breach At US Labor Agency</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

ETFs

AVGO

CHKP

CIBR

CRWD

CSCO

HACK

IHAK

OKTA

Pillar Of America's Cyber Security Lost Funding Temporarily: What Investors Should Know About CVE Program, Funding Extension

Equitable Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>) has outperformed the market over the past 5 years by 12.04% on an annualized basis producing an average annual return of 26.03%. Currently, Equitable Holdings has a market capitalization of $13.54 billion. 
Buying $100 In EQH: If an investor had bought $100 of EQH stock 5 years ago, it would be worth $303.39 today based on a price of $44.00 for EQH at the time of writing.
<h3>Equitable Holdings's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744902915_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Fidelity National Information Services shares are trading higher after the company announced it will buy a global payments issuer solutions business for $13.5 billion and provided Q1 guidance.

Loop Capital analyst Jeffrey Stevenson maintains AZEK Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) with a Hold and lowers the price target from $55 to $49.

AZEK

Loop Capital Maintains Hold on AZEK Co, Lowers Price Target to $49

Lockheed Martin shares are trading lower. The company announced management changes for its CFO and senior VP roles.

Barclays analyst Jason Goldberg maintains U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) with a Overweight and lowers the price target from $61 to $56.

Barclays Maintains Overweight on U.S. Bancorp, Lowers Price Target to $56

If you hold U.S.-listed Chinese stocks like Alibaba Group Holding Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NASDAQ">BABA</a>), JD.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) or PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), you may soon face serious liquidity risks, as delisting threats tied to geopolitical and regulatory frictions between Washington and Beijing <a href="https://www.benzinga.com/topic/tariffs">mount with fresh urgency.</a>
In a note shared Thursday, Goldman Sachs analyst Kinger Lau, CFA, said delisting fears for Chinese American Depositary Receipts (ADRs) are rising again, driven by escalating trade tensions and new policy guidance from U.S. officials, including President Donald Trump&#8216;s America First Investment Policy and Treasury Secretary Scott Bessent's statement that "everything is on the table" in the response to China's retaliatory tariffs.
According to Goldman Sachs&#8217; ADR Delisting Barometer, there is currently a 66% probability of delisting risk embedded in Chinese ADRs. A full pricing in of delisting risk could lead to a 9% drop in ADR valuations from current levels. 
&#8220;U.S. listings by Chinese companies is widely regarded as an embodiment of financial market relations and a leverage for the potential negotiation between the two nations,&#8221; Lau wrote.
<h1 class="wp-block-heading">How High Are The Stakes?</h1>
&#8220;We estimate that U.S. institutional investors currently own around U.S.$830 billion of Chinese stocks across A shares, H shares and ADRs,&#8221; Goldman Sachs stated. Of this, approximately $250 billion is tied up in ADRs specifically.
At the same time, Chinese investors could be forced to offload up to $1.7 trillion in U.S. financial assets, including approximately $370 billion in equities and $1.3 trillion in bonds.
This extreme scenario — which alludes to a full investment ban — would represent the largest forced unwind of cross-border holdings in modern financial history.
<h1 class="wp-block-heading">Who Gets Hit The Hardest?</h1>
According to Goldman's analysis, 5% of Alibaba's and 3% of PDD's market cap is owned by U.S. institutions that currently don't own other Hong Kong-listed stocks such as Tencent or Meituan. That means they may not have operational flexibility to pivot to Hong Kong in the event of delisting.
Roughly 20% of U.S. institutional holdings in top ADRs — equivalent to 7% of the total market cap — may face similar constraints, meaning they may be forced sellers.
For Alibaba, there are 1,275 institutional holders globally, and institutional investors collectively own 50% of the company&#8217;s outstanding shares. Out of that, 26% of Alibaba's total shares are held by U.S.-based institutions, with 176 U.S. institutional investors holding positions larger than 0.005% of the company's total shares.
For PDD, the figures are more concentrated: it has 1,006 institutional holders, with institutions holding 31% of the stock overall. 16% of the total shares are held by U.S. institutional investors, and there are 107 U.S.-based institutional holders with significant stakes (above 0.005% ownership).
In short, the data suggests Alibaba has both broader and deeper institutional engagement, especially from U.S. investors, compared to PDD. This means that, in the event of a U.S. delisting, Alibaba could see a greater volume of forced selling from U.S. institutional investors due to the larger size and scale of U.S. holdings.
<h1 class="wp-block-heading">Are ETFs And Derivatives at Risk?</h1>
Yes. Passive funds and ETF products are particularly exposed. The KraneShares CSI China Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWEB#NYSE">KWEB</a>) has 33% of its assets in ADRs, half of which do not have Hong Kong listings, making it vulnerable in a forced delisting scenario.
Other funds, like the iShares MSCI China ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCHI#NYSE">MCHI</a>), have already shifted weightings from ADRs to Hong Kong shares, thanks to changes in primary ticker designations by index providers like MSCI.
In derivatives markets, any forced delisting of ADRs could trigger early termination events under ISDA contracts, potentially unwinding outstanding options and swaps linked to these securities.
<h1 class="wp-block-heading">What Happens In A Delisting Event?</h1>
If a delisting takes place, investors may have a few paths forward depending on how the company is structured. For firms with dual listings, investors can convert their ADRs into Hong Kong-listed shares through the depositary bank. 
This process typically takes about two business days and may involve fees and applicable taxes. In some cases, investors might be able to sell their shares on over-the-counter (OTC) markets, although this route is blocked for companies delisted under the Holding Foreign Companies Accountable Act (HFCAA) or sanctioned by the Office of Foreign Assets Control (OFAC). 
If no action is taken by the investor, the ADR program will eventually be terminated and the depositary will sell the underlying shares, distributing the net proceeds in cash after deducting fees.
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44862662/trump-pressures-fed-as-ecb-delivers-7th-straight-rate-cut">Trump Pressures Fed As ECB Delivers 7th Straight Rate Cut</a></li>
</ul>
Photo: Shutterstock

Asia

Equities

Government

Large Cap

Macro Economic Events

Regulations

Specialty ETFs

Global

Econ #s

Economics

Tech

BABA

KWEB

MCHI

Citigourp Global Markets 2% Protected Notes Linked To The Djia

US-Listed Chinese Stocks Face $250 Billion Forced Selling Risk As Delisting Fears Emerge: What Investors Need To Know

Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) reported better-than-expected first-quarter <a href="https://www.benzinga.com/quote/abt/earnings">adjusted EPS results</a> on Wednesday.
Abbott Laboratories reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.40 billion. The U.S. MedTech giant reported adjusted EPS of $1.09, beating the consensus of $1.07 and the management guidance of $1.05-$1.09.
"Once again, Abbott's diversified business model delivered top-tier sales and EPS growth," said Robert Ford, chairman and CEO of Abbott. "It is this diversification and execution that allows Abbott to navigate through periods of uncertainty and continually deliver sustainable growth."
Abbott Laboratories expects second quarter 2025 adjusted EPS of $1.23-$1.27 versus consensus of $1.25.
Abbott Laboratories shares gained 0.9% to trade at $130.81 on Thursday.
These analysts made changes to their price targets on Abbott Laboratories following earnings announcement.
<ul>
<li>Jefferies analyst Matthew Taylor maintained Abbott Laboratories with a Hold and raised the price target from $135 to $137.</li>
<li>Stifel analyst Rick Wise maintained the stock with a Buy and raised the price target from $135 to $145.</li>
<li>Barclays analyst Matt Miksic maintained Abbott Laboratories with an Overweight and raised the price target from $158 to $159.</li>
</ul>
Considering buying ABT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="572" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111031/image-25-1024x572.png" alt="" class="wp-image-877000" style="width:539px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111031/image-25-1024x572.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111031/image-25-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111031/image-25-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17111031/image-25.png 1132w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44866413/netflix-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-3">Netflix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings

Barclays analyst Julien Roch maintains Omnicom Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMC#NYSE">OMC</a>) with a Overweight and lowers the price target from $110 to $105.

Barclays Maintains Overweight on Omnicom Group, Lowers Price Target to $105

Commodities

Press Releases

Corteva Announces Intent to Partner with bp to Develop Low Carbon Intensity Bio-Feedstock for Aviation Fuel Production

Corteva Announces Breakthrough in Wheat Technology

Corteva Agriscience Announces $3 Billion Share Repurchase Program

Corteva Highlights Breakthrough Innovation, Unveils New Financial Framework

Corteva Announces Dates for Fourth Quarter 2024 Earnings Release and Webcast

Dividends

Corteva Declares Quarterly Dividend

Corteva Strong 4Q Driven by Record Crop Demand, Disciplined Execution

Corteva to Participate in Bank of America Global Agriculture & Materials Conference

Siteimprove Appoints Nayaki Nayyar as New Chief Executive Officer

Corteva Announces Dates for First Quarter 2025 Earnings Release and Webcast

CTVA

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

Enlightify

Brazil Potash

Intrepid Potash

Mosaic

N2OFF

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

CVR Partners

Keybanc

Argus Research

Goldman Sachs

B of A Securities

RBC Capital

Comments

Corteva

Corteva (CTVA) Opciones

Corteva (NYSE:CTVA) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL